AstraZeneca Pharma India board to consider financial results

27 Jul 2012 Evaluate
AstraZeneca Pharma India has informed that a meeting of the board of directors of the company will be held on August 10, 2012, to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2012.

The above information is a part of company's filings submitted to BSE.

Astrazeneca Pharma I Share Price

7908.50 -183.50 (-2.27%)
04-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1709.40
Dr. Reddys Lab 1109.75
Cipla 1415.55
Lupin 1971.10
Zydus Lifesciences 866.65
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...